What one share of Veracyte holds
At Veracyte, we believe that exceptional cancer care begins with exceptional diagnostics. We are a global diagnostics company that empowers clinicians with the high-value insights they need to guide and assure patients at pivotal moments in the race to diagnose and treat cancer.
Veracyte’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $6.90 |
|---|---|
| Profit | $1.40 |
| Capex (buildings and equipment) | $0.15 |
| Free cash flow | $2.04 |
| Cash and investments | $3.73 |
| Book value | $17.28 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2011 | $4.56 | −$24.90 | $0.48 | −$23.79 | — | −$70.28 |
| 2012 | $17.88 | −$28.68 | $2.25 | −$13.27 | — | −$87.57 |
| 2013 | $5.26 | −$6.15 | $0.32 | −$4.93 | — | — |
| 2014 | $1.76 | −$1.36 | $0.09 | −$1.37 | — | $1.84 |
| 2015 | $1.90 | −$1.30 | $0.24 | −$1.27 | — | $1.85 |
| 2016 | $2.26 | −$1.09 | $0.15 | −$1.12 | — | $1.76 |
| 2017 | $2.12 | −$0.91 | $0.05 | −$0.76 | — | $1.10 |
| 2018 | $2.49 | −$0.62 | $0.05 | −$0.42 | — | $1.95 |
| 2019 | $2.61 | −$0.27 | $0.06 | −$0.13 | — | $4.83 |
| 2020 | $2.21 | −$0.66 | $0.05 | −$0.24 | — | $7.24 |
| 2021 | $3.23 | −$1.11 | $0.08 | −$0.55 | — | $15.42 |
| 2022 | $4.14 | −$0.51 | $0.12 | −$0.01 | — | $14.94 |
| 2023 | $4.97 | −$1.02 | $0.14 | $0.47 | — | $14.25 |
| 2024 | $5.70 | $0.31 | $0.14 | $0.82 | — | $15.12 |
| 2025 | $6.42 | $0.82 | $0.12 | $1.57 | — | $16.50 |
Common questions about Veracyte
How much does one share of Veracyte earn?
Over the last 12 months, each share of Veracyte earned $1.40 of profit on $6.90 of sales, keeping about 20¢ of every $1 (profit margin).
Does Veracyte pay a dividend?
Veracyte didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Veracyte’s book value per share?
Veracyte’s book value is $17.28 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of Veracyte have?
Each share of Veracyte has $3.73 of cash and investments, as of June 30, 2026.
What is Veracyte’s free cash flow per share?
$2.04 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.
Has Veracyte bought back shares?
Veracyte’s share count rose about 13790% from 2011 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.